Chimeric Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy (NCT06055439) | Chimeric Therapeutics | 2024-05-15 |
| CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma (NCT05627323) | Chimeric Therapeutics | 2023-06-06 |
Track Chimeric Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.